300636 同和药业
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资3,253--0000
投资性房地产0--0000
固定资产1,351,28934.03%1,008,211645,089571,660447,688
在建工程162,894-67.62%503,081772,970641,343306,992
无形资产19,712-2.26%20,16721,07721,43522,035
商誉0--0000
其他非流动资产531,7297.86%492,99761,77328,73325,758
2,068,8762.19%2,024,4561,500,9091,263,171802,473

流动资产
货币资金421,146-17.87%512,753141,964161,291280,404
应收账款108,45453.24%70,77287,83059,64619,564
存货526,0600.50%523,417497,358373,422335,414
其他流动资产205,498128.22%90,04230,79449,19729,814
1,261,1585.36%1,196,984757,946643,557665,196

流动负债
短期借款433,6561.01%429,312267,832182,293209,371
应付票据44,892-44.96%81,55998,38814,0980
应付帐款63,04829.10%48,835114,436129,68430,890
其他流动负债57,499-59.51%142,00594,38034,59217,848
599,095-14.62%701,711575,036360,668258,109
流动资产净值662,06333.68%495,273182,910282,889407,087
资产总额减流动负债2,730,9398.38%2,519,7291,683,8201,546,0601,209,560

非流动负债
长期借款399,00059.60%250,000326,333305,00069,000
应付债券0--00314,633296,599
其他非流动负债49,97515.47%43,27937,81838,31427,460
448,97553.09%293,279364,151657,947393,059

总权益
    实收股本421,527-0.38%423,136350,190205,906128,620
    储备项目1,860,4363.17%1,803,313969,478682,207687,881
股东权益2,281,9642.49%2,226,4491,319,669888,113816,501
非控股权益0--0000